Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11249579rdf:typepubmed:Citationlld:pubmed
pubmed-article:11249579lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:11249579lifeskim:mentionsumls-concept:C1373016lld:lifeskim
pubmed-article:11249579lifeskim:mentionsumls-concept:C0332185lld:lifeskim
pubmed-article:11249579pubmed:issue2lld:pubmed
pubmed-article:11249579pubmed:dateCreated2001-3-15lld:pubmed
pubmed-article:11249579pubmed:abstractTextThis paper covers the relevant scientific and patent literature published in the last two years concerning different classes of glycine antagonists and their potential application to therapeutic targets. Many of the molecules described here are approaching the final stages of clinical studies.lld:pubmed
pubmed-article:11249579pubmed:languageenglld:pubmed
pubmed-article:11249579pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11249579pubmed:citationSubsetIMlld:pubmed
pubmed-article:11249579pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11249579pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11249579pubmed:statusMEDLINElld:pubmed
pubmed-article:11249579pubmed:monthOctlld:pubmed
pubmed-article:11249579pubmed:issn1472-4472lld:pubmed
pubmed-article:11249579pubmed:authorpubmed-author:DonathEElld:pubmed
pubmed-article:11249579pubmed:authorpubmed-author:MichelsLLlld:pubmed
pubmed-article:11249579pubmed:authorpubmed-author:AntoliniMMlld:pubmed
pubmed-article:11249579pubmed:issnTypePrintlld:pubmed
pubmed-article:11249579pubmed:volume1lld:pubmed
pubmed-article:11249579pubmed:ownerNLMlld:pubmed
pubmed-article:11249579pubmed:authorsCompleteYlld:pubmed
pubmed-article:11249579pubmed:pagination230-5lld:pubmed
pubmed-article:11249579pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:11249579pubmed:meshHeadingpubmed-meshheading:11249579...lld:pubmed
pubmed-article:11249579pubmed:meshHeadingpubmed-meshheading:11249579...lld:pubmed
pubmed-article:11249579pubmed:meshHeadingpubmed-meshheading:11249579...lld:pubmed
pubmed-article:11249579pubmed:meshHeadingpubmed-meshheading:11249579...lld:pubmed
pubmed-article:11249579pubmed:meshHeadingpubmed-meshheading:11249579...lld:pubmed
pubmed-article:11249579pubmed:meshHeadingpubmed-meshheading:11249579...lld:pubmed
pubmed-article:11249579pubmed:year2000lld:pubmed
pubmed-article:11249579pubmed:articleTitleRecent developments in glycine antagonists.lld:pubmed
pubmed-article:11249579pubmed:affiliationGlaxo Wellcome SpA, Medicines Research Center, Via Fleming 4, 37100 Verona, Italy. fm20244@glaxowellcome.co.uklld:pubmed
pubmed-article:11249579pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11249579pubmed:publicationTypeReviewlld:pubmed